Overview Pembrolizumab (Keytruda): CADTH Reimbursement Suggestion: Indication: Together with chemotherapy, to the therapy of Grownup individuals with domestically recurrent unresectable or metastatic triple-destructive breast most cancers who definitely have not acquired prior chemotherapy for metastatic illness and whose tumours Specific programme